We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+16.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.9B
AUM Growth
+$5.25B
Cap. Flow
+$2.28B
Cap. Flow %
8.49%
Top 10 Hldgs %
25.71%
Holding
2,122
New
483
Increased
1,399
Reduced
210
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$148M
2
NVDA icon
NVIDIA
NVDA
+$57.1M
3
BABA icon
Alibaba
BABA
+$52.4M
4
TSLA icon
Tesla
TSLA
+$41.3M
5
STMP
Stamps.com, Inc.
STMP
+$37.6M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Consumer Discretionary 15.7%
3 Industrials 10.47%
4 Communication Services 9.84%
5 Healthcare 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBK icon
1901
Columbia Financial
CLBK
$1.13B
$165K ﹤0.01%
+10,587
New +$146K
HAPN
1902
Happen Inc
HAPN
$2.08B
$165K ﹤0.01%
+15,633
New +$105K
QTTB icon
1903
Q32 Bio
QTTB
$450M
$164K ﹤0.01%
806
+170
+27% +$32.9K
FRO icon
1904
Frontline
FRO
$8.75B
$163K ﹤0.01%
26,134
+11,670
+81% +$75K
KNL
1905
DELISTED
Knoll, Inc.
KNL
$163K ﹤0.01%
+11,099
New +$150K
COTY icon
1906
Coty
COTY
$2.33B
$161K ﹤0.01%
22,988
+3,147
+16% +$16.2K
BANC icon
1907
Banc of California
BANC
$3.28B
$158K ﹤0.01%
+10,737
New +$140K
CYH icon
1908
Community Health Systems
CYH
$385M
$158K ﹤0.01%
21,219
+8,573
+68% +$60.6K
CRNX icon
1909
Crinetics Pharmaceuticals
CRNX
$8.86B
$156K ﹤0.01%
+11,075
New +$154K
PRTA icon
1910
Prothena Corp
PRTA
$458M
$156K ﹤0.01%
12,974
+2,771
+27% +$32.8K
TBBK icon
1911
The Bancorp
TBBK
$2.79B
$156K ﹤0.01%
+11,423
New +$129K
TGI
1912
DELISTED
Triumph Group
TGI
$156K ﹤0.01%
+12,413
New +$129K
AHRT
1913
AH Realty Trust
AHRT
$534M
$155K ﹤0.01%
+13,854
New +$140K
CGEN icon
1914
Compugen
CGEN
$216M
$155K ﹤0.01%
12,787
-565
-4% -$7.79K
RUBY
1915
DELISTED
Rubius Therapeutics, Inc
RUBY
$155K ﹤0.01%
20,425
+3,015
+17% +$17.9K
EBSB
1916
DELISTED
Meridian Bancorp, Inc.
EBSB
$155K ﹤0.01%
+10,364
New +$138K
CLVS
1917
DELISTED
Clovis Oncology, Inc.
CLVS
$154K ﹤0.01%
32,004
+21,837
+215% +$110K
DTIL icon
1918
Precision BioSciences
DTIL
$188M
$153K ﹤0.01%
613
+142
+30% +$34.8K
TRST
1919
Trustco Bank Corp NY
TRST
$977M
$152K ﹤0.01%
4,566
+1,895
+71% +$57.1K
AKBA icon
1920
Akebia Therapeutics
AKBA
$327M
$151K ﹤0.01%
54,036
+13,388
+33% +$39.1K
IVR icon
1921
Invesco Mortgage Capital
IVR
$776M
$149K ﹤0.01%
4,397
+1,827
+71% +$56.6K
CBAY
1922
DELISTED
Cymabay Therapeutics
CBAY
$149K ﹤0.01%
25,981
+6,389
+33% +$48.4K
BDSI
1923
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$149K ﹤0.01%
35,484
+8,218
+30% +$31.7K
ARLO icon
1924
Arlo Technologies
ARLO
$1.4B
$148K ﹤0.01%
19,059
+8,052
+73% +$49K
TILE icon
1925
Interface
TILE
$1.91B
$147K ﹤0.01%
+14,046
New +$112K

Similar funds

ProShare Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, ProShare Advisors held 2,122 positions worth $26.9B, up 24% from $21.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors deployed $2.28B of net new capital in Q4 2020, opening 483 new positions and adding to 1,399 existing holdings. Its largest new stake was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $32.9M trimmed.

  • ProShare Advisors's largest Q4 2020 buy was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.
  • ProShare Advisors added most to Amazon in Q4 2020, an estimated $148M increase.
  • ProShare Advisors's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $32.9M.
  • ProShare Advisors fully exited The Aaron's Company Inc Class A in Q4 2020, selling an estimated $26.2M.
  • ProShare Advisors's ten largest holdings make up 26% of its $26.9B portfolio in Q4 2020.
  • ProShare Advisors opened 483 new positions and closed 29 in Q4 2020.
  • ProShare Advisors's portfolio value rose 24% quarter-over-quarter to $26.9B.

Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.